Hannah shares how she transitioned from a background in physics and medical imaging into implantable neurotechnology, and why neuromodulation offers transformative potential for conditions like depression, chronic pain, and stroke recovery. The conversation explores what's driving the growth of neurotech, from material and battery innovations to breakthroughs in brain connectivity research. and delves into the unique challenges of therapy personalisation, device usability, and clinical rollout. Hannah also tackles the hype around BCIs, the impact of players like Neuralink, and the ethical considerations surrounding patient data and autonomy.
